Dr Reddys Laboratories (RDY) Asset Writedowns and Impairment (2012 - 2026)

Dr Reddys Laboratories' Asset Writedowns and Impairment history runs 13 years deep, the most recent figure standing at $28.3 million for Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment rose 218.97% year-over-year to $28.3 million; the TTM figure through Mar 2026 stood at $39.3 million (up 97.26% YoY), while the FY2026 annual figure was $38.0 million, up 90.0% from the prior year.
• Asset Writedowns and Impairment was $28.3 million for Q1 2026 at Dr Reddys Laboratories, up from $3.0 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $28.3 million in Q1 2026 to a low of -$11.2 million in Q3 2025.
• Historically, Asset Writedowns and Impairment has averaged $4.8 million across 5 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment jumped 33266613.4% in 2023, then tumbled 201.12% in 2025.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $7.0 million in 2022, then slumped by 81.13% to $1.3 million in 2023, then tumbled by 103.59% to -$47374.8 in 2024, then surged by 6523.65% to $3.0 million in 2025, then soared by 829.57% to $28.3 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $28.3 million (Q1 2026), $3.0 million (Q4 2025), and -$11.2 million (Q3 2025), per Business Quant data.